LIONETTI, MARTA
 Distribuzione geografica
Continente #
EU - Europa 8.051
NA - Nord America 4.469
AS - Asia 2.282
SA - Sud America 101
OC - Oceania 43
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.967
Nazione #
US - Stati Uniti d'America 4.335
DE - Germania 3.210
GB - Regno Unito 2.147
CN - Cina 1.330
IT - Italia 792
SE - Svezia 552
IN - India 237
RU - Federazione Russa 233
TR - Turchia 225
KR - Corea 186
UA - Ucraina 185
IE - Irlanda 182
FR - Francia 180
FI - Finlandia 126
CA - Canada 122
EU - Europa 122
NL - Olanda 105
HK - Hong Kong 84
CO - Colombia 58
PL - Polonia 53
DK - Danimarca 46
BE - Belgio 45
JP - Giappone 43
SG - Singapore 41
ES - Italia 39
AU - Australia 37
CH - Svizzera 36
GR - Grecia 29
VN - Vietnam 27
RO - Romania 24
BR - Brasile 19
ID - Indonesia 19
CZ - Repubblica Ceca 13
AR - Argentina 12
PT - Portogallo 12
TW - Taiwan 11
IR - Iran 10
TH - Thailandia 10
AT - Austria 9
HU - Ungheria 8
MX - Messico 8
MY - Malesia 8
PH - Filippine 8
SA - Arabia Saudita 7
NZ - Nuova Zelanda 6
PK - Pakistan 6
BG - Bulgaria 5
CL - Cile 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
HR - Croazia 4
IL - Israele 4
NO - Norvegia 4
AL - Albania 3
EG - Egitto 3
GE - Georgia 3
JO - Giordania 3
LI - Liechtenstein 3
MU - Mauritius 3
QA - Qatar 3
SC - Seychelles 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BD - Bangladesh 2
LB - Libano 2
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
DZ - Algeria 1
GA - Gabon 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 15.084
Città #
Frankfurt am Main 2.020
Southend 1.931
Chandler 443
Seattle 374
Beijing 360
Fairfield 288
Wilmington 285
Milan 265
Princeton 250
Ashburn 192
Houston 192
Dublin 170
Mountain View 150
Woodbridge 149
Dearborn 148
Jacksonville 132
Nanjing 130
Ann Arbor 121
Redmond 119
Cambridge 104
Toronto 85
Des Moines 79
Somerville 74
Andover 73
Berlin 73
Shanghai 70
Sakarya 68
Boardman 65
Serra 65
Hong Kong 63
Bengaluru 61
Jinan 60
Bogotá 57
Hangzhou 55
Redwood City 51
Shenyang 51
Changsha 47
Eitensheim 46
Saint Petersburg 46
Phoenix 43
Nanchang 39
Guangzhou 36
Kiez 32
Tianjin 32
Helsinki 30
Hanover 29
Hebei 29
Grafing 28
New York 28
Zhengzhou 28
Warsaw 27
Athens 25
Fuzhou 24
Falls Church 23
Hamburg 22
Seoul 22
San Diego 21
Bitonto 20
Brussels 19
London 19
Naples 19
Silver Spring 18
Kunming 17
Odernheim 17
Hefei 16
Roxbury 15
Sunnyvale 15
Nürnberg 14
Taiyuan 14
Chicago 13
Jiaxing 13
Würzburg 13
Changchun 12
Rochester 12
Bern 11
Chengdu 11
Ottawa 11
Rome 11
Santa Clara 11
Stockholm 11
Wuhan 11
Auburn Hills 10
Central 10
Istanbul 10
Putian 10
Taizhou 10
Bologna 9
São Paulo 9
Verona 9
Dong Ket 8
Fremont 8
Geisenheim 8
Kuala Lumpur 8
Los Angeles 8
Medford 8
Mumbai 8
Norwalk 8
Turin 8
Washington 8
Bangalore 7
Totale 10.037
Nome #
Utilizing next-generation sequencing in the management of multiple myeloma 1.143
Clinical-biological characterization of variant B chronic lymphocytic leukemia, characterized by a mantle cell lymphoma-like immunophenotype, t(11;14)(q13;q32) negative 404
BIOLOGICAL AND CLINICAL RELEVANCE OF MIRNA EXPRESSION SIGNATURES IN PRIMARY PLASMA CELL LEUKEMIA 264
A distinctive trascriptional profile characterizes the chromosome 17p loss in B-cell chronic lymphocytic leukemia 222
Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns 217
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma 213
Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia 207
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias 196
MicroRNA genes associated with genomic alterations or gene expression modulation contribute to enhance genetic heterogeneity in Multiple Myeloma 192
B-cell receptor configuration and adverse cytogenetics are associated to a higher risk of autoimmune hemolytic anemia in the course of chronic lymphocytic leukemia 189
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 189
Analisi del numero di copie e sequenza del DNA in campioni sequenziali di melanoma alla diagnosi e recidiva=DNA copy number and whole-exome sequencing analyses in sequential myeloma samples at diagnosis and relapse 186
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 185
Impact of Host Genes and Strand Selection on miRNA and miRNA* Expression 182
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation 179
Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature 178
The expression pattern of small nucleolar and small cajal body-specific RNAS characterizes distinct molecular subtypes of multiple myeloma 177
Long non-coding RNAs in normal and malignant hematopoiesis 177
A novel fish-based normalization procedure for whole genome microarrays detecting accurate local copy numbers : application to multiple myeloma 171
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia 168
Synthetic miR-34a mimics as a novel therapeutic agent for Multiple Myeloma : in vitro and in vivo evidence 168
Clinico-biological characterization of a subset of variant B-CLL, defined according to a combined cytofluorimetric/fish diagnostic approach 165
Integrative genomic analysis of trisomy 12 abnormality in B-cell chronic lymphocytic leukemia 164
Clonal evolution in therapy-related neoplasms 162
Molecular classification and pharmacogenetics of primary plasma cell leukemia: an initial approach toward precision medicine 160
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 159
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia 157
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles 156
Biological and Clinical Relevance of Surrogate Markers of IgVH Mutational Status in B-Cell Chronic Lymphocytic Leukemia 154
Analysis of Stereotyped IGHV distribution in a series of 1133 chronic lymphocytic leukemia patients : the experience of a multicenter Italian Study Group 154
IGHV gene analysis in chronic lymphocytic leukemia 153
The investigation of genomic profiles in plasma cell leukemias by means of an integrative microarray approach 152
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma 151
Analysis of hiperdiploidy in Multiple Myeloma by fluorescence in situ hybridization. 149
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia 149
Molecular and transcriptional characterization of 17P loss in B-cell chronic lymphocytic leukemia 148
Integrative genomic approach identifies deregulated micrornas in human myeloma cell lines 147
Integrative genomic analysis of primary plasma cell leukemia revealed strong gene and microrna dosage effect 147
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 147
Global SNP-based mapping of B-cell chronic lymphocytic leukemia reveals the role of 2p gain in predicting clinical outcome 144
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma : an integrated genomics approach reveals a wide gene dosage effect 143
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 141
Gene and mirna expression profiles in plasma cell leukemias 141
Deregulated microrna expression patterns are associated with high-rish genetic groups in multiple myeloma 140
Stereotyped B-cell receptor is associated with immune thrombocytopenia in CLL 140
Integrative high-resolution microarrays approach in B-cell chronic lymphocytic leukemia reveals the presence of molecularly distinct subgroups in patients with 13Q deletion 138
A novel fish-based normalization procedure for whole genome microarrays detection accurate local copy numbers : application to multiple myeloma 138
Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines 138
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia 138
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 137
Genome-wide DNA copy number analysis by SNP arrays of B-cell chronic lymphocytic leukemia reveals the presence of novel molecular lesions 136
High-resolution microarray characterization of the 13q14 deletion extent in B-cell chronic lymphocytic leukemia : correlation with copy number and expression levels of mir-15a/16 cluster 136
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia 135
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 133
From integration of mirnas and genes expression profiles to reconstruction and analysis of regulatory networks 131
Pleiotropic anti-myeloma activity of ITF2357 : inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b 131
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma 131
Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome 130
Novel surrogate markers of IGVH mutational status in B-cell chronic lymphocytic leukemia 130
Integrative genomic approach based on SNP-array and gene expression profiling reveals the presence of molecularly distinct subgroups in early stage b-cell chronic lymphocytic leukemia 129
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion 127
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 126
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 124
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 124
Critical analysis of transcriptional and post-transcriptional regulatory networks in multiple myeloma 122
Stereotyped B-cell receptors in chronic lymphocytic leukemia : a biological and clinical compendium from a multicenter italian cohort 120
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients 120
Identification of myeloma-associated miRNA and their prognostic value : a compendium from UK MRC myeloma IX trial 119
Reconstruction of transcriptional regulatory networks in multiple myeloma 117
The clinical and biological features of a series of immunophenotypic variant of B-CLL 116
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients 116
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications 115
Integrative genomic approach in B-cell chronic lymphocytic leukemia : definition of molecularly distinct subgroups of patients with 13Q14 deletion 114
Multiple myeloma post-transcriptional regulatory network reconstructed by integrated analysis of microrna and gene expression profiles 111
Transcriptome analysis of primary plasma cell leukemia tumors from a multicenter prospective gimena study : biological and clinical implications 111
CD26 expression in mature B-cell neoplasia : its possible role as a new prognostic marker in B-CLL 110
Stereotyped B-cell receptors in chronic lymphocytic leukemia : a compendium from a multicenter italian cohort 110
Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma 109
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia : a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 107
Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma 105
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of CLL 104
Relevance of chromosome 2P gain in early Binet stage A chronic lymphocytic leukemia 104
Micro-RNA and gene expression profiling in chronic lymphocytic leukemia-like (CLL-LIKE) clinical monoclonal B lymphocytosis and RAI-0 CLL : a comparative analysis of a prospective multicenter osservational study 103
Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL) 103
PRO-APOPTOTIC EFFECT OF A NEW SMAC-MIMETIC ON B-CLL CELLS IN VITRO 102
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines 102
Compendium of FAM46C gene mutations in plasma cell dyscrasias 102
Identification of microrna expression patterns and definition of a micrornas/mrna regulatory network in distinct molecular groups of multiple myeloma 101
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma 101
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles 100
Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors 99
Integrative analysis of DNA copy number and expression levels of MIR-15a/16-1 cluster in B-cell chronic lymphocytic leukemia patients with 13q14 deletion 93
Critical analysis of transcriptional and post-transcriptional regulatory networks in multiple myeloma 93
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 93
microRNAome expression in chronic lymphocytic leukemia : comparison with normal B cell subsets and correlations with prognostic and clinical parameters 92
Global methylation patterns in primary plasma cell leukemia 89
The apobec mutational activity in multiple myeloma: from diagnosis to cell lines 87
Prospective validation of a risk score based on biological markers for predicting progression free survival in binet stage a chronic lymphocytic leukemia patients : Results of the multicenter O-CLL1-GISL study 86
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort 85
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma 83
Totale 15.086
Categoria #
all - tutte 32.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019527 0 0 0 0 0 0 0 0 0 137 255 135
2019/20201.925 254 140 109 162 140 207 230 122 203 236 68 54
2020/20211.603 148 113 78 73 136 119 79 98 183 93 384 99
2021/20221.503 113 68 81 79 146 114 135 74 190 125 78 300
2022/20231.682 268 162 141 185 178 320 58 106 135 29 75 25
2023/20242.684 27 72 59 89 284 184 657 561 269 482 0 0
Totale 15.832